Literature DB >> 9663445

Melittin, a metabostatic peptide inhibiting Gs activity.

N Fukushima1, M Kohno, T Kato, S Kawamoto, K Okuda, Y Misu, H Ueda.   

Abstract

Some basic amphiphilic peptides are known to directly stimulate heterotrimeric GTP-binding proteins (G proteins). Mastoparan and melittin are known to stimulate Gi activities. Here, we found melittin inhibited guanine nucleotide-dependent adenylyl cyclase activity in synaptic membranes of the rat cerebral cortex. However, in insect cell membranes overexpressing specific heterotrimeric G proteins using baculovirus expression system, melittin showed unique effects different from those by mastoparan on G protein activities. This peptide markedly stimulated Gi1 and G11 activities, whereas it did inhibit Gs activities. Kinetic studies revealed that the inhibition of Gs activity by melittin is attributed to the inhibition of GDP release in exchange for added guanine nucleotides (or the association of guanine nucleotides). Thus, melittin may be the first metabostatic peptide inhibiting G protein (Gs) activity, and both mechanisms through the stimulation of Gi and inhibition of Gs might be involved in the melittin-induced inhibition of adenylyl cyclase.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9663445     DOI: 10.1016/s0196-9781(98)00027-8

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  10 in total

Review 1.  Review of the anticancer activities of bee products.

Authors:  Pongsathon Premratanachai; Chanpen Chanchao
Journal:  Asian Pac J Trop Biomed       Date:  2014-05

2.  Inhibition of GTPase activity of Gi proteins and decreased agonist affinity at M2 muscarinic acetylcholine receptors by spermine and methoctramine.

Authors:  L Daeffler; A Chahdi; J P Gies; Y Landry
Journal:  Br J Pharmacol       Date:  1999-06       Impact factor: 8.739

3.  UVB radiation-induced β-catenin signaling is enhanced by COX-2 expression in keratinocytes.

Authors:  Kimberly A Smith; Xin Tong; Adnan O Abu-Yousif; Carol C Mikulec; Cara J Gottardi; Susan M Fischer; Jill C Pelling
Journal:  Mol Carcinog       Date:  2011-08-18       Impact factor: 4.784

4.  β1-Adrenergic receptors activate two distinct signaling pathways in striatal neurons.

Authors:  John Meitzen; Jessie I Luoma; Christopher M Stern; Paul G Mermelstein
Journal:  J Neurochem       Date:  2011-01-19       Impact factor: 5.372

5.  Cyclic AMP concentrations in dendritic cells induce and regulate Th2 immunity and allergic asthma.

Authors:  Jihyung Lee; Tae Hoon Kim; Fiona Murray; Xiangli Li; Sara S Choi; David H Broide; Maripat Corr; Jongdae Lee; Nicholas J G Webster; Paul A Insel; Eyal Raz
Journal:  Proc Natl Acad Sci U S A       Date:  2015-01-20       Impact factor: 11.205

6.  CD150high Bone Marrow Tregs Maintain Hematopoietic Stem Cell Quiescence and Immune Privilege via Adenosine.

Authors:  Yuichi Hirata; Kazuhiro Furuhashi; Hiroshi Ishii; Hao Wei Li; Sandra Pinho; Lei Ding; Simon C Robson; Paul S Frenette; Joji Fujisaki
Journal:  Cell Stem Cell       Date:  2018-02-15       Impact factor: 24.633

7.  Evolution of class-specific peptides targeting a hot spot of the Galphas subunit.

Authors:  Ryan J Austin; William W Ja; Richard W Roberts
Journal:  J Mol Biol       Date:  2008-01-18       Impact factor: 5.469

8.  Heterodimerization of β2 adrenergic receptor and somatostatin receptor 5: Implications in modulation of signaling pathway.

Authors:  Rishi K Somvanshi; Nicole Chaudhari; Xiaofan Qiu; Ujendra Kumar
Journal:  J Mol Signal       Date:  2011-08-12

Review 9.  Three valuable peptides from bee and wasp venoms for therapeutic and biotechnological use: melittin, apamin and mastoparan.

Authors:  Miguel Moreno; Ernest Giralt
Journal:  Toxins (Basel)       Date:  2015-04-01       Impact factor: 4.546

Review 10.  Strategies towards Targeting Gαi/s Proteins: Scanning of Protein-Protein Interaction Sites To Overcome Inaccessibility.

Authors:  Britta Nubbemeyer; Anna Pepanian; Ajay Abisheck Paul George; Diana Imhof
Journal:  ChemMedChem       Date:  2021-03-22       Impact factor: 3.466

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.